Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

This manual contains valuable information about working with silicone vs. thermoplastics, silicone use for medical applications, choosing the right silicone
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

FDA warns Signal Medical on unapproved hip implants

May 27, 2015 by Brad Perriello

The FDA sends a warning letter to Signal Medical, flagging it for making unapproved changes to its MicroSeal hip implants.

FDA warns Signal Medical on unapproved hip implants

The FDA flagged Signal Medical Corp. for selling a hip implant after making changes that weren't approved by the federal safety watchdog.

Study: Heart valve coatings prolong durability

May 27, 2015 by Brad Perriello

A study of replacement heart valves treated with calcification-reducing coatings shows that the coatings prolong valve durability.

Study: Heart valve coatings prolong durability

ConMed ripe for M&A | The week in medtech M&A

May 27, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: ConMed ripe for M&A spree; Baxter looks to growth post-Baxalta spinout; Sorin shareholders OK Cyberonics Merger

Analyst: ConMed ripe for M&A spree

May 19, 2015 by Fink Densford

Analyst: ConMed ripe for M&A spree

Mela Sciences recalls MelaFind

May 27, 2015 by Fink Densford

Mela Sciences recalls its flagship MelaFind melanoma diagnosis system because some of its software wasn't included in its FDA approval.

Mela Sciences recalls MelaFind device

Mela Sciences (NSDQ:MELA) recalled its flagship MelaFind melanoma diagnosis aid because some of its software wasn't included in its pre-market approval from the FDA.

Founders buy back Alere Analytics, rebrand as Persivia

May 27, 2015 by Fink Densford

The founders of DiagnosisOne, which became Alere Analytics, buy the business back and rebrand as Persivia.

Founders buy back Alere Analytics, rebrand as Persivia

The husband-and-wife team that founded the company that eventually became Alere Analytics bought the business back and rebranded it as Persivia.

Financial terms were not disclosed.

Study: DAPT duration after drug-eluting stent surgery unclear

May 26, 2015 by Fink Densford

A new study of patients treated with long-duration dual-antiplatelet therapies after the placement of drug-eluting stents shows a lower rate of heart attack but a higher risk for major bleeding events.

DAPT duration after drug-eluting stent surgery unclear

Patients treated with long-duration anti-platelet therapies after the placement of a drug-eluting stent showed lower rates of heart attack but higher rates of major bleeding events and a slight increase in mortality, according to a new study released today.

MassDevice.com +3 | The top 3 medtech stories for May 26, 2015

May 26, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Medtech trio sets $297m offering terms

May 26, 2015 by Brad Perriello

A trio of medical device companies - Evolent Health, EndoChoice and Corindus Vascular Robotics - sets terms for public offerings today that could bring in a collective $297 million.

IPO Tuesday: Medtech trio sets offering terms

A trio of medtech companies set terms for their upcoming public offerings today, announcing plans to raise a collective $297 million.